Jane Street’s Avanos Medical AVNS Stock Holding History

Jane Street’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$702K	Buy	+28,200	New	+$660K	﹤0.01%	7291

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Jane Street's AVNS Position: Q2 2026 in Review

Jane Street reduced its Avanos Medical (AVNS) stake by 23% in Q2 2026, selling an estimated $1.08M and leaving 152,971 shares worth $3.81M. The position accounts for ﹤0.01% of the portfolio, ranked #4128.

Jane Street first reported a position in AVNS in Q3 2015 and has held it in 22 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Jane Street held 152,971 shares of Avanos Medical worth $3.81M as of Q2 2026.
Jane Street sold 46,225 Avanos Medical shares in Q2 2026, an estimated $1.08M.
Avanos Medical made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4128 holding.
Jane Street first reported a position in Avanos Medical in Q3 2015 and has held it in 22 quarters since.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.